Search research articles
Contact Us
Filters
Showing results (61-70 of 78) with videos related to
Page
of 8
Sort By:
Applied and Environmental Microbiology
|
March 1, 1989
Significance of microflora in proteolysis in the colon
S A Gibson, C McFarlan, S Hay, et al.
Gut
|
December 20, 2003
Systemic antibodies towards mucosal bacteria in ulcerative colitis and Crohn's disease differentially activate the innate immune response
E Furrie, S Macfarlane, J H Cummings, et al.
The Journal of Applied Bacteriology
|
February 1, 1990
Effect of different carbohydrates on growth, polysaccharidase and glycosidase production by Bacteroides ovatus, in batch and continuous culture
G T Macfarlane, S Hay, S Macfarlane, et al.
The Journal of Applied Bacteriology
|
November 1, 1989
Influence of retention time on degradation of pancreatic enzymes by human colonic bacteria grown in a 3-stage continuous culture system
G T Macfarlane, J H Cummings, S Macfarlane, et al.
Current Microbiology
|
May 1, 1997
Starch utilization by Bacteroides ovatus isolated from the human large intestine
B A Degnan, S Macfarlane, M E Quigley, et al.
Alimentary Pharmacology & Therapeutics
|
August 21, 2013
Synbiotic consumption changes the metabolism and composition of the gut microbiota in older people and modifies inflammatory processes: a randomised, double-blind, placebo-controlled crossover study
S Macfarlane, S Cleary, B Bahrami, et al.
Journal of Applied Microbiology
|
September 29, 1998
Growth of a human intestinal Desulfovibrio desulfuricans in continuous cultures containing defined populations of saccharolytic and amino acid fermenting bacteria
D F Newton, J H Cummings, S Macfarlane, et al.
The Journal of Applied Bacteriology
|
January 1, 1988
Contribution of the microflora to proteolysis in the human large intestine
G T Macfarlane, C Allison, S A Gibson, et al.
The British Journal of Nutrition
|
May 10, 2005
Mucosal bacteria in ulcerative colitis
S Macfarlane, E Furrie, A Kennedy, et al.
Current Pharmaceutical Design
|
May 16, 2009
The gut microbiota in inflammatory bowel disease
G T Macfarlane, K L Blackett, T Nakayama, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 78) with videos related to
Sort By:
Page
of 8
Applied and Environmental Microbiology
|
March 1, 1989
Significance of microflora in proteolysis in the colon
S A Gibson, C McFarlan, S Hay, et al.
Gut
|
December 20, 2003
Systemic antibodies towards mucosal bacteria in ulcerative colitis and Crohn's disease differentially activate the innate immune response
E Furrie, S Macfarlane, J H Cummings, et al.
The Journal of Applied Bacteriology
|
February 1, 1990
Effect of different carbohydrates on growth, polysaccharidase and glycosidase production by Bacteroides ovatus, in batch and continuous culture
G T Macfarlane, S Hay, S Macfarlane, et al.
The Journal of Applied Bacteriology
|
November 1, 1989
Influence of retention time on degradation of pancreatic enzymes by human colonic bacteria grown in a 3-stage continuous culture system
G T Macfarlane, J H Cummings, S Macfarlane, et al.
Current Microbiology
|
May 1, 1997
Starch utilization by Bacteroides ovatus isolated from the human large intestine
B A Degnan, S Macfarlane, M E Quigley, et al.
Alimentary Pharmacology & Therapeutics
|
August 21, 2013
Synbiotic consumption changes the metabolism and composition of the gut microbiota in older people and modifies inflammatory processes: a randomised, double-blind, placebo-controlled crossover study
S Macfarlane, S Cleary, B Bahrami, et al.
Journal of Applied Microbiology
|
September 29, 1998
Growth of a human intestinal Desulfovibrio desulfuricans in continuous cultures containing defined populations of saccharolytic and amino acid fermenting bacteria
D F Newton, J H Cummings, S Macfarlane, et al.
The Journal of Applied Bacteriology
|
January 1, 1988
Contribution of the microflora to proteolysis in the human large intestine
G T Macfarlane, C Allison, S A Gibson, et al.
The British Journal of Nutrition
|
May 10, 2005
Mucosal bacteria in ulcerative colitis
S Macfarlane, E Furrie, A Kennedy, et al.
Current Pharmaceutical Design
|
May 16, 2009
The gut microbiota in inflammatory bowel disease
G T Macfarlane, K L Blackett, T Nakayama, et al.
Page
of 8